ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy

BACKGROUND: Sensitive and reliable biomarkers for early detection of recurrence are needed to improve post-definitive radiation risk stratification, disease management, and outcomes for patients with unresectable early-stage or locally advanced non-small cell lung cancer (NSCLC) who are treated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Lebow, Emily S., Shaverdian, Narek, Eichholz, Jordan E., Kratochvil, Leah B., McCune, Megan, Murciano-Goroff, Yonina R., Jee, Justin, Eng, Juliana, Chaft, Jamie E., Kris, Mark G., Kalashnikova, Ekaterina, Feeney, Jordan, Scalise, Carly Bess, Sudhaman, Sumedha, Palsuledesai, Charuta C., Malhotra, Meenakshi, Krainock, Michael, Sethi, Himanshu, Aleshin, Alexey, Liu, Minetta C., Shepherd, Annemarie F., Wu, Abraham J., Simone, Charles B., Gelblum, Daphna Y., Johnson, Kaylie A., Rudin, Charles M., Gomez, Daniel R., Razavi, Pedram, Reis-Filho, Jorge S., Isbell, James M., Li, Bob T., Rimner, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546425/
https://www.ncbi.nlm.nih.gov/pubmed/37795442
http://dx.doi.org/10.3389/fonc.2023.1253629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546425/
https://www.ncbi.nlm.nih.gov/pubmed/37795442
http://dx.doi.org/10.3389/fonc.2023.1253629

Ejemplares similares